Company Filing History:
Years Active: 2011-2013
Title: Dario Pastorello: Innovator in Pharmaceutical Processes
Introduction
Dario Pastorello is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the purification and synthesis of important compounds. With a total of 2 patents, his work has the potential to impact the medical industry positively.
Latest Patents
Dario's latest patents include a process for the purification of Rufinamide and a process for the synthesis of Pregabalin. The purification process involves specific methodologies aimed at enhancing the quality of Rufinamide, a compound used in treating epilepsy. The synthesis process focuses on the preparation of a compound of formula (I), which is crucial for developing effective medications.
Career Highlights
Dario Pastorello is currently associated with Dipharma Francis S.r.l., where he applies his expertise in pharmaceutical processes. His work at the company has allowed him to explore innovative solutions that contribute to the advancement of drug development.
Collaborations
Dario has collaborated with notable colleagues such as Pietro Allegrini and Gabriele Razzetti. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the pharmaceutical field.
Conclusion
Dario Pastorello's contributions to pharmaceutical innovations through his patents and collaborations highlight his role as a key figure in the industry. His work continues to pave the way for advancements in medication development and purification processes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.